In this webinar, we will expand upon major changes that have occurred in the specialty drug market over the past quarter.
- New and Existing Code Updates – HCPCS Codes: J Codes, Q Codes: Biosimilars, Revisions, Deletions, Billable Unit Changes
- Pricing Updates: Price changes, Price Trends, Medicare Allowable (ASP) Highlights
- Issues Observed: Impact, Approaches to resolve
- Annual Update – ICD10-CM: Additions, Deletions, Revisions
- Specialty Drug Pipeline: Specialty FDA Reviews Expected in Q4 2019